This Viewpoint supports SDG 3 by highlighting the pervasive issues within health systems rooted in ableism and proposes an agenda to tackle ableism, aiming to make health systems responsive to the needs of people with disabilities.

This study investigates the therapeutic potential of nervonic acid (NA) in alleviating stroke-induced brain damage and post-stroke depression behaviors in rats, revealing that NA can improve neurological recovery, reduce infarct volume, and enhance depressive-like behaviors by modulating gut microbiota and metabolite activity. The findings suggest that NA could be a promising treatment option for stroke and associated post-stroke depression.

Rare Disease Education:  Necrotizing Enterocolitis

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  Acoustic Neuroma

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  Von Hippel-Lindau Disease

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  Alpha-1 Antitrypsin Deficiency

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  Myasthenia Gravis

Editor: Kelsey LaFayette, DNP, RN, FNP-C

The annual observance of the International Day of Disabled Persons was proclaimed in 1992, by the United Nations General Assembly resolution 47/3.